by Eric Christianson | Jan 18, 2026 | Endocrine Case Studies
Prescribing cascades don’t usually start with “bad” medications. In fact, they often begin with some of our most effective therapies. Metformin, SGLT2 inhibitors, and GLP-1 receptor agonists all have strong outcome data in type 2 diabetes. But when adverse effects are...
by Eric Christianson | Dec 17, 2023 | Endocrine Medication and Disease State Clinical Pearls
Semaglutide products have been popping up in news headlines recently, and not because of their continued popularity as effective weight loss medications. Data from poison control centers across the country indicates a drastic increase over the past year in calls...
by Eric Christianson | Dec 3, 2023 | Endocrine Medication and Disease State Clinical Pearls
Many institutions that pass medications need to be aware of when medications expire. The GLP-1 agonist class has been quickly expanding so we wanted to put together a storage chart to ensure that healthcare professionals and patients properly store their medications....
by Eric Christianson | Aug 16, 2023 | Polypharmacy Cases And The Prescribing Cascade
As a geriatric pharmacist, I’m always on high alert for the prescribing cascade. I outline my top 5 examples of the prescribing cascade in diabetes care in this article. Metformin and Loperamide Metformin has been the go-to first-line agent of choice for years....
by Eric Christianson | Aug 9, 2023 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls
There’s always this voice in the back of my head that always cautions me that all that glitters is not gold. After being heralded as the next savior in weight loss by the media, the GLP-1 Agonists/GIP agonists have come under more scrutiny lately in the news. A...
